Disease-free survival (DFS) rates based on EOC MRD in patients with ETP, near-ETP, and non-ETP with a day-29 MRD ≥1%. Five-year DFS for (A) total cohort: 69.6% ± 8.6% for patients with EOC MRD ≥0.01% and 88.7% ± 3.4% for patients with EOC MRD <0.01% (P = .0055); (B) ETP: 88.9% ± 10.5% for EOC MRD ≥0.01% and 90.4% ± 7.2% for EOC MRD <0.01% (P = .7642); (C) near-ETP: 75.0% ± 15.3% for EOC MRD ≥0.01% and 78.6% ± 10.5% for EOC MRD <0.01% (P = .7406); and (D) non-ETP: 58.2% ± 18.8% for EOC MRD ≥0.01% and 89.3% ± 5.0% for EOC MRD <0.01% (P = .0042).